These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1703215)

  • 21. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
    Vreede FT; Huismans H
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
    Wiegers KJ; Wetz K; Dernick R
    J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains.
    Heine HG; Haritou M; Failla P; Fahey K; Azad A
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1835-43. PubMed ID: 1651980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization epitopes of human rhinovirus type 2.
    Appleyard G; Russell SM; Clarke BE; Speller SA; Trowbridge M; Vadolas J
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1275-82. PubMed ID: 1693662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
    Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
    J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
    Hewat EA; Blaas D
    EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
    Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
    J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.
    Toogood CI; Crompton J; Hay RT
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1429-35. PubMed ID: 1376769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence.
    Casal JI; Langeveld JP; Cortés E; Schaaper WW; van Dijk E; Vela C; Kamstrup S; Meloen RH
    J Virol; 1995 Nov; 69(11):7274-7. PubMed ID: 7474152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
    Anderson S; Momoeda M; Kawase M; Kajigaya S; Young NS
    Virology; 1995 Jan; 206(1):626-32. PubMed ID: 7530397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1.
    Pulli T; Roivainen M; Hovi T; Hyypiä T
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain variability and localization of important epitopes on the major structural protein (VP2) of infectious pancreatic necrosis virus.
    Heppell J; Tarrab E; Lecomte J; Berthiaume L; Arella M
    Virology; 1995 Dec; 214(1):40-9. PubMed ID: 8525637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies.
    van der Werf S; Briand JP; Plaué S; Burckard J; Girard M; Van Regenmortel MH
    Res Virol; 1994; 145(6):349-59. PubMed ID: 7535942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries.
    Davies JM; Cai YP; Weir RC; Rowley MJ
    Virology; 2000 Sep; 275(1):67-76. PubMed ID: 11017788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.
    Yoshimoto K; Rosenfeld S; Frickhofen N; Kennedy D; Hills R; Kajigaya S; Young NS
    J Virol; 1991 Dec; 65(12):7056-60. PubMed ID: 1719240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
    Hewat EA; Marlovits TC; Blaas D
    J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.
    Clatch RJ; Pevear DC; Rozhon E; Roos RP; Miller SD; Lipton HL
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3191-6. PubMed ID: 2826657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.